PDF herunterladen
Horm Metab Res 2013; 45(01): 74-77
DOI: 10.1055/s-0032-1323704
Humans, Clinical
© Georg Thieme Verlag KG Stuttgart · New York

HLA-A2 Phenotype may be Protective Against Graves’ Disease but not Against Hashimoto’s Thyroiditis in Caucasians

C. Bernecker
1   Division for Endocrinology, Diabetes and Rheumatology, University Hospital Duesseldorf, Duesseldorf, Germany
,
M. Ostapczuk
2   Institute of Experimental Psychology, Heinrich-Heine University Duesseldorf, Duesseldorf, Germany
,
S. Vordenbäumen
1   Division for Endocrinology, Diabetes and Rheumatology, University Hospital Duesseldorf, Duesseldorf, Germany
,
M. Ehlers
1   Division for Endocrinology, Diabetes and Rheumatology, University Hospital Duesseldorf, Duesseldorf, Germany
,
A. Thiel
1   Division for Endocrinology, Diabetes and Rheumatology, University Hospital Duesseldorf, Duesseldorf, Germany
,
S. Schinner
1   Division for Endocrinology, Diabetes and Rheumatology, University Hospital Duesseldorf, Duesseldorf, Germany
,
H. Willenberg
1   Division for Endocrinology, Diabetes and Rheumatology, University Hospital Duesseldorf, Duesseldorf, Germany
,
W. A. Scherbaum
1   Division for Endocrinology, Diabetes and Rheumatology, University Hospital Duesseldorf, Duesseldorf, Germany
,
M. Schott
1   Division for Endocrinology, Diabetes and Rheumatology, University Hospital Duesseldorf, Duesseldorf, Germany
› Institutsangaben
Weitere Informationen

Publikationsverlauf

received 02. Mai 2012

accepted 26. Juli 2012

Publikationsdatum:
12. September 2012 (online)

Auch verfügbar auf
    Lizenzen und Reprints

Abstract

Graves’ disease (GD) and Hashimoto’s thyroiditis (HT) are the most common autoimmune thyroid diseases (AITDs) affecting up to 5% of the general population. In Caucasians HT has a prevalence of up to 4.60% and GD a prevalence of 1–2%. The aim of this study was to investigate the association between HLA-A2 and the AITDs GD and HT among Caucasians. HLA alleles of 33 patients with GD and 75 patients with HT were determined by serological typing. The frequency of HLA A2 was significantly reduced in GD (p=0.033) but not in HT (p=n.s.) as compared to control samples. In individuals positive for HLA-A2 odds ratio for protection from GD was found to be 2.8. This study supports the hypothesis that genetic predisposition to GD is not restricted to MHC class II molecules. The significant negative association between HLA A2 and GD supports the hypothesis that MHC class I genes may be relevant for the protection from GD. In contrast the nonsignificant results for HT indicate that this association may not apply to AITDs in general.

Key words

autoimmune thyroiditis - Graves’ disease - Hashimoto’s thyroiditis - major histocompatibility complex (MHC) - autoimmunity - thyroid epidemiology
 

  • References

  • 1 Ehlers M, Thiel A, Bernecker C, Porwol D, Papewalis C, Willenberg HS, Schinner S, Hautzel H, Scherbaum WA, Schott M. Evidence of a Combined Cytotoxic Thyroglobulin and Thyroperoxidase Epitope-Specific Cellular Immunity in Hashimoto’s Thyroiditis. J Clin Endocrinol Metab 2012; 97: 1347-1354
    Google Scholar
  • 2 Pearce EN, Farwell AP, Braverman LE. Thyroiditis. N Engl J Med 2003; 2646-2655
    PubMedGoogle Scholar
  • 3 Aust G, Hofmann A, Laue S, Ode-Hakim S, Scherbaum WA. Differential regulation of granulocyte-macrophage colony-stimulating factor mRNA and protein expression in human thyrocytes and thyroid-derived fibroblasts by interleukin-1 alpha and tumor necrosis factor-alpha. J Endocrinol 1996; 151: 277-285
    CrossrefPubMedGoogle Scholar
  • 4 Jacobson EM, Tomer Y. The CD40, CTLA-4, thyroglobulin, TSH receptor, and PTPN22 gene quintet and its contribution to thyroid autoimmunity: back to the future. J Autoimmun 2007; 28: 85-98
    CrossrefPubMedGoogle Scholar
  • 5 Schott M, Minich WB, Willenberg HS, Papewalis C, Seissler J, Feldkamp J, Bergmann A, Scherbaum WA, Morgenthaler NG. Relevance of TSH receptor stimulating and blocking autoantibody measurement for the prediction of relapse in Graves’ disease. Horm Metab Res 2005; 37: 741-744
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 6 Zöphe K, Roggenbuck D, von Landenberg P, Wunderlich G, Grüning T, Kotzerke J, Lackner KJ, Rees Smith B. TSH receptor antibody (TRAb) assays based on the human monoclonal autoantibody M22 are more sensitive than bovine TSH based assays. Horm Metab Res 2010; 42: 65-69
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 7 Prummel MF, Strieder T, Wiersinga WM. The environment and autoimmune thyroid diseases. Eur J Endocrinol 2004; 150: 605-618
    CrossrefPubMedGoogle Scholar
  • 8 Tomer Y, Davies TF. Searching for the autoimmune thyroid disease susceptibility genes: from gene mapping to gene function. Endocr Rev 2003; 24: 694-717
    CrossrefPubMedGoogle Scholar
  • 9 Ban Y, Tomer Y. Susceptibility genes in thyroid autoimmunity. Clin Dev Immunol 2005; 12: 47-58
    CrossrefPubMedGoogle Scholar
  • 10 Simmonds MJ, Gough SCL. Unravelling the genetic complexity of autoimmune thyroid disease: HLA, CTLA-4 and beyond. Clin Exp Immunol 2004; 136: 1-10
    CrossrefPubMedGoogle Scholar
  • 11 Nelson JL, Hansen JA. Autoimmune diseases and HLA. Crit Rev Immunol 1990; 10: 307-328
    PubMedGoogle Scholar
  • 12 Yanagawa T, Mangklabruks A, Chang YB, Okamoto Y, Fisfalen ME, Curran PG, DeGroot LJ. Human histocompatibility leukocyte antigen-DQA1*0501 allele associated with genetic susceptibility to Graves’ disease in a Caucasian population. J Clin Endocrinol Metab 1993; 76: 1569-1574
    CrossrefPubMedGoogle Scholar
  • 13 Marga M, Denisova A, Sochnev A, Pirags V, Farid NR. Two HLA DRB 1 alleles confer independent genetic susceptibility to Graves disease: relevance of cross-population studies. Am J Med Genet 2001; 102: 188-191
    CrossrefPubMedGoogle Scholar
  • 14 Zamani M, Spaepen M, Bex M, Bouillon R, Cassiman JJ. Primary role of the HLA class II DRB1*0301 allele in Graves disease. Am J Med Genet 2000; 95: 432-437
    CrossrefPubMedGoogle Scholar
  • 15 Mangklabruks A, Cox N, DeGroot LJ. Genetic factors in autoimmune thyroid disease analyzed by restriction fragment length polymorphisms of candidate genes. J Clin Endocrinol Metab 1991; 73: 236-244
    CrossrefPubMedGoogle Scholar
  • 16 Farid N. Graves’ disease. In: Farid NR. (ed.). Hla in endocrine and metabolic disorders. New York: Academic Press; 1981: 85-143
    Google Scholar
  • 17 Stenszky V, Kozma L, Balázs C, Rochlitz S, Bear JC, Farid NR. The genetics of Graves’ disease: HLA and disease susceptibility. J Clin Endocrinol Metab 1985; 61: 735-740
    CrossrefPubMedGoogle Scholar
  • 18 Gough SCL, Simmonds MJ. The HLA Region and Autoimmune Disease: Associations and Mechanisms of Action. Curr Genomic 2007; 8: 453-465
    PubMedGoogle Scholar
  • 19 Tandon N, Zhang L, Weetman AP. HLA associations with Hashimoto’s thyroiditis. Clin Endocrinol 1991; 34: 383-386
    Google Scholar
  • 20 Petrone A, Giorgi A, Mesturino CA, Capizzi M, Cascino I, Nistico L, Osborn J, Di Mario U, Buzzetti R. Association of DRB1*04-DQB1*0301 haplotype and lack of association of two polymorphic sites at CTLA-4 gene with Hashimoto’s thyroiditis in an Italian population. Thyroid 2001; 11: 171-175
    Google Scholar
  • 21 Inoue D, Sato K, Enomoto T, Sugawa H, Maeda M, Inoko H, Tsuji K, Mori T, Imura H. Correlation of HLA types and clinical findings in Japanese patients with hyperthyroid Graves’ disease: evidence indicating the existence of four subpopulations. Clin Endocrinol 1992; 36: 75-82
    CrossrefPubMedGoogle Scholar
  • 22 Chan SH, Lin YN, Wee GB, Ren EC, Lui KF, Cheah JS. Human leucocyte antigen DNA typing in Singaporean Chinese patients with Graves’ disease. Ann Acad Med Singap 1993; 22: 576-579
    PubMedGoogle Scholar
  • 23 Brixner V, Mosebach M, Schmidt M, Hermann S, Seifried E, Martin H, Seidl C. HLA-DRB1*0826 and HLA-DQB1*0627, two novel class II alleles identified in blood stem cell donors of Caucasian origin. Tissue Antigens 2006; 67: 160-162
    CrossrefPubMedGoogle Scholar
  • 24 Gonzalez-Galarza FF, Christmas S, Middleton D, Jones AR. Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations. Nucleic Acids Res 2011; 39: 913-919
    CrossrefPubMedGoogle Scholar
  • 25 Schott M, Hermsen D, Broecker-Preuss M, Casati M, Mas JC, Eckstein A, Gassner D, Golla R, Graeber C, van Helden J, Inomata K, Jarausch J, Kratzsch J, Miyazaki N, Moreno MAN, Murakami T, Roth HJ, Stock W, Noh JY, Scherbaum WA, Mann K. Clinical value of the first automated TSH receptor autoantibody assay for the diagnosis of Graves’ disease (GD): an international multicentre trial. Clin Endocrinol 2009; 71: 566-573
    CrossrefPubMedGoogle Scholar
  • 26 Herbert R. Confidence interval calculator. Sydney: The George Institute for Global Health; 2011
    Google Scholar
  • 27 Cohen J. Statistical power analysis for the behavioral sciences. Hove: Lawrence Erlbaum Associates; 1988
    Google Scholar
  • 28 Tomer Y, Davies TF. Searching for the autoimmune thyroid disease susceptibility genes: from gene mapping to gene function. Endocr Rev 2003; 24: 694-717
    CrossrefPubMedGoogle Scholar
  • 29 Farid NR, Sampson L, Moens H, Barnard JM. The association of goitrous autoimmune thyroiditis with HLA-DR5. Tissue Antigens 1981; 17: 265-268
    PubMedGoogle Scholar
  • 30 Hanafusa T, Pujol-Borrell R, Chiovato L, Russell RC, Doniach D, Bottazzo GF. Aberrant expression of HLA-DR antigen on thyrocytes in Graves’ disease: relevance for autoimmunity. Lancet 1983; 2: 1111-1115
    PubMedGoogle Scholar
  • 31 Dong RP, Kimura A, Okubo R, Shinagawa H, Tamai H, Nishimura Y, Sasazuki T. HLA-A and DPB1 loci confer susceptibility to Graves’ disease. Hum Immunol 1992; 35: 165-172
    CrossrefPubMedGoogle Scholar
  • 32 Kawa A, Nakamura Nakazawa M, Sakaguchi S, Kawabata T, Maeda Y, Kanehisa T. HLA-BW35 and B5 in Japanese patients with Graves’ disease. Acta Endocrinol 1977; 86: 754-757
    PubMedGoogle Scholar
  • 33 Onuma H, Ota M, Sugenoya A, Inoko H. Association of HLA-DPB1*0501 with early-onset Graves’ disease in Japanese. Hum Immunol 1994; 39: 195-201
    CrossrefPubMedGoogle Scholar
  • 34 Katsuren E, Awata T, Matsumoto C, Yamamoto K. HLA class II alleles in Japanese patients with Graves’ disease: weak associations of HLA-DR and -DQ. Endocr J 1994; 41: 599-603
    CrossrefPubMedGoogle Scholar
  • 35 Ohtsuka K, Nakamura Y. Human leukocyte antigens associated with hyperthyroid Graves ophthalmology in Japanese patients. Am J Ophthalmol 1998; 126: 805-810
    CrossrefPubMedGoogle Scholar
  • 36 Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, Braverman LE. Serum TSH T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002; 87: 489-499
    Google Scholar
  • 37 Jacobson DL, Gange SJ, Rose NR, Graham NM. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 1997; 84: 223-243
    Google Scholar
  • 38 Kasagi K, Takahashi N, Inoue G, Honda T, Kawachi Y, Izumi Y. Thyroid function in Japanese adults as assessed by a general health checkup system in relation with thyroid-related antibodies and other clinical parameters. Thyroid 2009; 19: 937-944
    CrossrefPubMedGoogle Scholar
  • 39 Yamashita S, Amino N, Shong YK. The American Thyroid Association and American Association of Clinical Endocrinologists hyperthyroidism and other causes of thyrotoxicosis guidelines: viewpoints from Japan and Korea. Thyroid 2011; 21: 577-580
    CrossrefPubMedGoogle Scholar
  • 40 Jacobson EM, Huber A, Tomer Y. The HLA gene complex in thyroid autoimmunity: from epidemiology to etiology. J Autoimmun 2008; 30: 58-62
    CrossrefPubMedGoogle Scholar
  • 41 Davies TF, Amino N. A new classification for human autoimmune thyroid disease. Thyroid 1993; 3: 331-333
    CrossrefPubMedGoogle Scholar
  • 42 Yoshida H, Amino N, Yagawa K, Uemura K, Satoh M, Miyai K, Kumahara Y. Association of serum antithyroid antibodies with lymphocytic infiltration of the thyroid gland: studies of seventy autopsied cases. J Clin Endocrinol Metab 1978; 46: 859-862
    Google Scholar